Phylloseptin-Pba

General Information


DRACP ID  DRACP00587

Peptide Name   Phylloseptin-Pba

Sequence  FFSMIPKIAGGIASLVKNL

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Phyllomedusa baltea

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H460 Lung large cell carcinoma Carcinoma IC50=4.3µM MTT assay 24h 1
PC-3 Prostate carcinoma Carcinoma IC50=2.9µM MTT assay 24h 1
U-251MG Astrocytoma Carcinoma IC50=1.8µM MTT assay 24h 1

Hemolytic Activity  Horse erythrocytes: 1.4% Hemolysis=8µg/ml; Human erythrocytes: 80% Hemolysis=128µg/ml

Normal (non-cancerous) Cytotoxicity  HMEC-1: IC50=36.6µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00587

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H156N22O23S

Absent amino acids  CDEHQRTWY

Common amino acids  I

Mass  232773

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  10

Net charge  2

Boman Index  1791

Hydrophobicity  111.05

Aliphatic Index  128.42

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26633506

Title  Phylloseptin-PBa--A Novel Broad-Spectrum Antimicrobial Peptide from the Skin Secretion of the Peruvian Purple-Sided Leaf Frog (Phyllomedusa Baltea) Which Exhibits Cancer Cell Cytotoxicity

Doi 10.3390/toxins7124878

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.